Αποτελέσματα Αναζήτησης
Pfizer and BioNTech conclude Phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy endpoints. Published November 18, 2020. Accessed October 27, 2021. https://www.pfizer.com/ news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine. Pfizer.
3 Μαΐ 2022 · A timeline of critical events in the COVID-19 vaccine development progress. WHO has approved the emergency use of ten vaccines (including three India vaccines, COVISHIELD, COVAXIN, and...
2 Μαρ 2021 · Launched in April 2020, this tracker aims to collate up-to-date information on all COVID-19 vaccine candidates from inception through to deployment, enabling policy makers, researchers, and the public to keep informed of the rapid developments.
A typical vaccine development timeline takes 5 to 10 years, and sometimes longer, to assess whether the vaccine is safe and efficacious in clinical trials, complete the regulatory approval processes, and manufacture sufficient quantity of vaccine doses for widespread distribution.
21 Ιουλ 2020 · Timelines of COVID-19 vaccines. Tulsi Chugh. Author information Article notes Copyright and License information PMC Disclaimer. World Health Organisation discussed the “Top Threats to Human Health in 2019,” and developed a strategic plan to meet the challenges. Among the communicable diseases.
Vaccine development timeline. November 2019. Retrospective studies suggest the first confirmed case of Covid-19 came on 17 November, in Wuhan, China. January 2020. Chinese...
11 Σεπ 2023 · The goal of this study was to compare the research and development (R&D), launch and scale up timelines of COVID-19 and non-COVID-19 vaccines and derive key lessons learnt from the COVID-19 pandemic and their implications for the development, launch and scale up of vaccines for other diseases.
